Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce that its subsidia ...

Proteomics International Laboratories’ OxiDx has secured an Australian patent for a finger-prick test to measure muscle ...

The probiotic-rich drink kefir may be a potential complementary treatment for Alzheimer’s disease by helping improve ...

Drug-induced liver injury (DILI) is a significant concern in clinical practice, arising from medications, herbs, and dietary ...

Precision diagnostics company Proteomics International Laboratories Ltd (ASX:PIQ) has been granted a patent in Australia for ...

Atherosclerosis (AS) is a chronic inflammatory disease characterized by the buildup of lipids and immune cells in arterial ...

The most detailed brain metabolism simulation reveals new molecular targets for dementia treatment, offering hope to restore ...

Flavonoids show promise in treating type 2 diabetes mellitus by targeting the enteroendocrine system and regulating key gut ...

Blindness or vision loss is a growing concern among older adults, and one of the leading causes is a condition known as ...

Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related conditions, today provided shareholders with an update on its ...

The geroscience hypothesis holds that targeting molecular pathways that drive aging can give us more healthy years. Evidence ...

February was heart month, and this is the last column in a series about the major risk factors for heart attacks. Heart ...